
Statin diabetes risk similar in women and men, but data gaps limit precision
An umbrella review of 21 statin trials with sex-disaggregated data finds statin use raises incident type 2 diabetes risk by about 25% overall, with similar increases in women (OR 1.28) and men (OR 1.24). The study highlights underrepresentation of women and a lack of study-level sex-specific data, which prevents precise absolute-risk estimates or assessment of statin-specific effects, underscoring the need for more research and sex-stratified reporting to inform personalized statin therapy.












